EQ-5D studies in nervous system diseases in eight Central and East European countries: a systematic literature review

Valentina Prevolnik Rupel, Marko Divjak, Zsombor Zrubka, Fanni Rencz, L. Gulácsi, Dominik Golicki, Dagmara Mirowska-Guzel, Judit Simon, Valentin Brodszky, Petra Baji, Jakub Závada, Guenka Petrova, Alexandru Rotar, Márta Péntek

Research output: Contribution to journalArticle

Abstract

Backround: Guidelines for economic analyses of health care technologies require local input data for reimbursement decisions in the countries of Central and Eastern Europe (CEE). The aim of this study was to systematically review and analyse the available empirical studies using the EQ-5D instrument as a measure of the health-related quality of life (HRQoL) in patients with neurological diseases. Methods: A systematic literature search was performed up to 1st April 2018 to identify relevant studies in eight selected CEE countries. Original articles reporting on studies of neurological diseases using the EQ-5D instrument were analysed. Results: Thirty-six articles, describing the results of 38 samples of patients and a total of 13,005 patients were included in the review. Most studies were from Hungary (44.4%) and none from Romania or Slovakia. EQ-5D utility scores were reported in 33 (91.7%) articles. In multiple sclerosis (MS) being the most represented disease, the average utility scores ranged from 0.49 in Austria to 0.80 in Poland with a weighted average of 0.69. EQ VAS scores for MS ranged from 39 in Czech Republic to 72.0 in Poland, with weighted average of 59.1. MS patients, together with epilepsy and essential tremor patients, estimated their HRQoL among the highest. Conclusions: EQ-5D research activity in neurology has been increasing through the years in studied CEE countries. There are clinical areas with the significant social burden, such as a migraine or meningitis, that are completely lacking data, other areas, such as stroke or epilepsy, with very scarce data.

Original languageEnglish
Pages (from-to)109-117
Number of pages9
JournalEuropean Journal of Health Economics
Volume20
DOIs
Publication statusPublished - Jun 1 2019

Fingerprint

Nervous System Diseases
Eastern Europe
Multiple Sclerosis
Poland
Epilepsy
Quality of Life
Essential Tremor
Romania
Slovakia
Biomedical Technology
Hungary
Austria
Czech Republic
Neurology
Migraine Disorders
Meningitis
Stroke
Economics
European countries
Literature review

Keywords

  • Central and Eastern European countries
  • EQ-5D
  • Health-related quality of life
  • Neurological diseases

ASJC Scopus subject areas

  • Economics, Econometrics and Finance (miscellaneous)
  • Health Policy

Cite this

EQ-5D studies in nervous system diseases in eight Central and East European countries : a systematic literature review. / Prevolnik Rupel, Valentina; Divjak, Marko; Zrubka, Zsombor; Rencz, Fanni; Gulácsi, L.; Golicki, Dominik; Mirowska-Guzel, Dagmara; Simon, Judit; Brodszky, Valentin; Baji, Petra; Závada, Jakub; Petrova, Guenka; Rotar, Alexandru; Péntek, Márta.

In: European Journal of Health Economics, Vol. 20, 01.06.2019, p. 109-117.

Research output: Contribution to journalArticle

Prevolnik Rupel, V, Divjak, M, Zrubka, Z, Rencz, F, Gulácsi, L, Golicki, D, Mirowska-Guzel, D, Simon, J, Brodszky, V, Baji, P, Závada, J, Petrova, G, Rotar, A & Péntek, M 2019, 'EQ-5D studies in nervous system diseases in eight Central and East European countries: a systematic literature review', European Journal of Health Economics, vol. 20, pp. 109-117. https://doi.org/10.1007/s10198-019-01068-9
Prevolnik Rupel, Valentina ; Divjak, Marko ; Zrubka, Zsombor ; Rencz, Fanni ; Gulácsi, L. ; Golicki, Dominik ; Mirowska-Guzel, Dagmara ; Simon, Judit ; Brodszky, Valentin ; Baji, Petra ; Závada, Jakub ; Petrova, Guenka ; Rotar, Alexandru ; Péntek, Márta. / EQ-5D studies in nervous system diseases in eight Central and East European countries : a systematic literature review. In: European Journal of Health Economics. 2019 ; Vol. 20. pp. 109-117.
@article{203b1a7f679648cb981882413b7391e4,
title = "EQ-5D studies in nervous system diseases in eight Central and East European countries: a systematic literature review",
abstract = "Backround: Guidelines for economic analyses of health care technologies require local input data for reimbursement decisions in the countries of Central and Eastern Europe (CEE). The aim of this study was to systematically review and analyse the available empirical studies using the EQ-5D instrument as a measure of the health-related quality of life (HRQoL) in patients with neurological diseases. Methods: A systematic literature search was performed up to 1st April 2018 to identify relevant studies in eight selected CEE countries. Original articles reporting on studies of neurological diseases using the EQ-5D instrument were analysed. Results: Thirty-six articles, describing the results of 38 samples of patients and a total of 13,005 patients were included in the review. Most studies were from Hungary (44.4{\%}) and none from Romania or Slovakia. EQ-5D utility scores were reported in 33 (91.7{\%}) articles. In multiple sclerosis (MS) being the most represented disease, the average utility scores ranged from 0.49 in Austria to 0.80 in Poland with a weighted average of 0.69. EQ VAS scores for MS ranged from 39 in Czech Republic to 72.0 in Poland, with weighted average of 59.1. MS patients, together with epilepsy and essential tremor patients, estimated their HRQoL among the highest. Conclusions: EQ-5D research activity in neurology has been increasing through the years in studied CEE countries. There are clinical areas with the significant social burden, such as a migraine or meningitis, that are completely lacking data, other areas, such as stroke or epilepsy, with very scarce data.",
keywords = "Central and Eastern European countries, EQ-5D, Health-related quality of life, Neurological diseases",
author = "{Prevolnik Rupel}, Valentina and Marko Divjak and Zsombor Zrubka and Fanni Rencz and L. Gul{\'a}csi and Dominik Golicki and Dagmara Mirowska-Guzel and Judit Simon and Valentin Brodszky and Petra Baji and Jakub Z{\'a}vada and Guenka Petrova and Alexandru Rotar and M{\'a}rta P{\'e}ntek",
year = "2019",
month = "6",
day = "1",
doi = "10.1007/s10198-019-01068-9",
language = "English",
volume = "20",
pages = "109--117",
journal = "European Journal of Health Economics",
issn = "1618-7598",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - EQ-5D studies in nervous system diseases in eight Central and East European countries

T2 - a systematic literature review

AU - Prevolnik Rupel, Valentina

AU - Divjak, Marko

AU - Zrubka, Zsombor

AU - Rencz, Fanni

AU - Gulácsi, L.

AU - Golicki, Dominik

AU - Mirowska-Guzel, Dagmara

AU - Simon, Judit

AU - Brodszky, Valentin

AU - Baji, Petra

AU - Závada, Jakub

AU - Petrova, Guenka

AU - Rotar, Alexandru

AU - Péntek, Márta

PY - 2019/6/1

Y1 - 2019/6/1

N2 - Backround: Guidelines for economic analyses of health care technologies require local input data for reimbursement decisions in the countries of Central and Eastern Europe (CEE). The aim of this study was to systematically review and analyse the available empirical studies using the EQ-5D instrument as a measure of the health-related quality of life (HRQoL) in patients with neurological diseases. Methods: A systematic literature search was performed up to 1st April 2018 to identify relevant studies in eight selected CEE countries. Original articles reporting on studies of neurological diseases using the EQ-5D instrument were analysed. Results: Thirty-six articles, describing the results of 38 samples of patients and a total of 13,005 patients were included in the review. Most studies were from Hungary (44.4%) and none from Romania or Slovakia. EQ-5D utility scores were reported in 33 (91.7%) articles. In multiple sclerosis (MS) being the most represented disease, the average utility scores ranged from 0.49 in Austria to 0.80 in Poland with a weighted average of 0.69. EQ VAS scores for MS ranged from 39 in Czech Republic to 72.0 in Poland, with weighted average of 59.1. MS patients, together with epilepsy and essential tremor patients, estimated their HRQoL among the highest. Conclusions: EQ-5D research activity in neurology has been increasing through the years in studied CEE countries. There are clinical areas with the significant social burden, such as a migraine or meningitis, that are completely lacking data, other areas, such as stroke or epilepsy, with very scarce data.

AB - Backround: Guidelines for economic analyses of health care technologies require local input data for reimbursement decisions in the countries of Central and Eastern Europe (CEE). The aim of this study was to systematically review and analyse the available empirical studies using the EQ-5D instrument as a measure of the health-related quality of life (HRQoL) in patients with neurological diseases. Methods: A systematic literature search was performed up to 1st April 2018 to identify relevant studies in eight selected CEE countries. Original articles reporting on studies of neurological diseases using the EQ-5D instrument were analysed. Results: Thirty-six articles, describing the results of 38 samples of patients and a total of 13,005 patients were included in the review. Most studies were from Hungary (44.4%) and none from Romania or Slovakia. EQ-5D utility scores were reported in 33 (91.7%) articles. In multiple sclerosis (MS) being the most represented disease, the average utility scores ranged from 0.49 in Austria to 0.80 in Poland with a weighted average of 0.69. EQ VAS scores for MS ranged from 39 in Czech Republic to 72.0 in Poland, with weighted average of 59.1. MS patients, together with epilepsy and essential tremor patients, estimated their HRQoL among the highest. Conclusions: EQ-5D research activity in neurology has been increasing through the years in studied CEE countries. There are clinical areas with the significant social burden, such as a migraine or meningitis, that are completely lacking data, other areas, such as stroke or epilepsy, with very scarce data.

KW - Central and Eastern European countries

KW - EQ-5D

KW - Health-related quality of life

KW - Neurological diseases

UR - http://www.scopus.com/inward/record.url?scp=85066013204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066013204&partnerID=8YFLogxK

U2 - 10.1007/s10198-019-01068-9

DO - 10.1007/s10198-019-01068-9

M3 - Article

C2 - 31098882

AN - SCOPUS:85066013204

VL - 20

SP - 109

EP - 117

JO - European Journal of Health Economics

JF - European Journal of Health Economics

SN - 1618-7598

ER -